在癌症中基于化学抗原受体的自然杀手细胞免疫疗法:从长椅到床边
Beibei Zhang1, Mengzhe Yang2, Weiming Zhang3
1Institute of Biomedical Research, Yunnan University, Kunming, 650500, China. zhangb@ynu.edu.cn.
Cell death & disease
|January 14, 2024
概括
工程自然杀手 (NK) 细胞,包括仿真抗原受体 (CAR) -NK细胞,提供了有前途的癌症免疫疗法替代品. 这篇评论详细介绍了NK细胞生物学,CAR-NK治疗设计以及未来对抗癌症的临床潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 免疫疗法,特别是仿真抗原受体 (CAR) -T细胞疗法,在癌症治疗方面取得了进步,但面临成本和毒性等局限性.
- 自然杀手 (NK) 细胞是重要的免疫成分,作为癌症发展的早期反应者.
- 卡尔-T细胞在血液癌症中表现出成功,但存在相关的挑战.
研究的目的:
- 为提供NK细胞发育,功能和治疗应用的最新审查.
- 探索工程NK细胞疗法,特别是CAR-NK细胞的合理性和设计策略.
- 将CAR-NK细胞与CAR-T细胞进行比较,并讨论当前的挑战和未来的方向.
主要方法:
- 关于NK细胞生物学和工程NK细胞疗法的文献综述.
- 对NK细胞的CAR设计原则的分析.
- 讨论NK细胞基础免疫疗法的临床前和临床试验数据.
主要成果:
- NK细胞具有显著的抗瘤潜力,在癌症中充当"第一响应者".
- CAR-NK细胞是CAR-T细胞的可行替代品,具有明显的优势和设计考虑.
- 目前正在进行的研究和临床试验正在探索CAR-NK疗法的疗效和安全性.
结论:
- 工程NK细胞疗法,特别是CAR-NK细胞,对未来的癌症治疗进展具有重大前景.
- 了解NK细胞生物学和CAR设计对于优化这些疗法至关重要.
- 进一步的研究和临床调查是必要的,以充分实现基于NK细胞的免疫疗法的潜力.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cytotoxic T Cells-mediated Immune Response
921
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921


